Resultados de la búsqueda 321-330 de 3001 para anti-TNF drugs

  1. Neurología - Ensayos clínicos

    ... drugs in the iPSC-derived muscle cells. A Study to Clarify the Relationship Between Autonomic Nervous System Regulation and Cognitive Performance. Rochester ...

  2. Youtube-Mayo Clinic Minute 2 reasons not to share pain pills

    Vivien Williams: El Dr. Mike Hooten, experto en manejo del dolor de Mayo Clinic, explica dos grandes motivos por los que no debes compartir analgésicos opioides ...

  3. Terapia con testosterona: beneficios y riesgos potenciales a medida que envejeces - Mayo Clinic

    Salud sexual. Más información; Testosterone therapy Potential benefits and risks as you age. Tu donación es muy poderosa... ¿quieres hacerla hoy mismo? Para ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Drugs used in chemotherapy, such as daunorubicin and cytarabine, work in different ways to stop the growth of cancer cells, either by killing the cells, by ...

  5. Lactancia materna y medicamentos: ¿qué es seguro? - Mayo Clinic

    Reaffirmed 2014. Wambach K, et al., eds. Drug therapy and breastfeeding. In: Breastfeeding and Human Lactation. 5th ed. Sudbury, Mass.: Jones and Bartlett ...

  6. Terapia cognitivo conductual - Mayo Clinic

    Behavior Research and Therapy. 2016;87:109. Cognitive behavioural therapy (CBT). Royal College of Psychiatrists. https://www.rcpsych.ac.uk/mental-health/ ...

  7. Neurología - Ensayos clínicos

    ... treatment (including surgery, radiation and/or adjuvant or neoadjuvant chemotherapy). ... drugs in the iPSC-derived muscle cells. Cerebral Spinal Fluid Evaluation ...

  8. Vitamina C en dosis altas: ¿mata las células cancerosas? - Mayo Clinic

    Ascorbic acid in cancer treatment: Let the Phoenix fly. Cancer Cell. 2018; doi:10.1016/j.ccell.2018.07.014. Vitamin C. Natural Medicines. https ...

  9. Gastroenterología y Hepatología - Ensayos clínicos

    The purpose of this study is to investigate the response rate of dietary therapy in patients with Eosinophilic Esophagitis (EoE) and determine rates of long- ...

  10. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    ADPKD is a leading cause of end-stage renal disease. Recently, a new medication called Tolvaptan has been approved by the FDA to slow progression of ADPKD.